The organoid breakthrough pushing research toward real drug impact

Organoids are transforming how researchers build human‑relevant disease models, especially when animal systems can’t capture key biology. Partnering with LICORbio has helped one lab better protect these sensitive structures by minimizing time outside the incubator and enabling high‑quality, multi‑scale 3D imaging with the LICORbio Atlas™ Imaging System. In this SelectScience interview, Dr. Rodrigo Cristofoletti, Director of the Center for Pharmacometrics and Systems Pharmacology at the University of Florida, shares how these advances are accelerating organoid research and why he’s excited about the field’s shift from academic innovation to real‑world drug development.

This video was filmed at SLAS 2026.